Qlik announces that Lupin Limited (Lupin), a transnational pharmaceutical company based in Mumbai, has integrated Qlik to unlock data insights across their organization.
Lupin is using Qlik to analyze data across its supply chain, finance, and research and development departments in order to drive rapid and fact-based decisions for the business. Utilizing the Qlik platform, Lupin is able to integrate and analyze huge volumes of data from multiple sources – including SAP ERP, SAP Business Warehouse, Microsoft Excel, and Sales Force Automation, as well as a third party information management system.
“Information is the lifeblood of any organization and particularly in the fast moving sector of pharmaceuticals,” said Rajendra Chunodkar, Executive Vice President, Global Supply Chain & Technology, Lupin. “Increasing supply chain efficiency begins with enhancing basic metrics and reporting, as these provide the essential data for performance improvement initiatives and provide visibility of supply chain activities. Our supply chain metrics not only mirrors the performance of the supply chain function at Lupin, but also helps in evaluating the performance of other functions like manufacturing, procurement, customer servicing. Qlik helps us identify inefficiencies whether by market, a specific product range, a production facility or vendor delays. These help us in taking focused corrective action. With Qlik’s ‘control metrics’, we can monitor real time critical events and KPIs. The platform empowers our business to make better decisions to increase supply chain responsiveness, optimize cost, and enhance customer service.”
Through its new Qlik-powered Lupin Enhanced Analytical Portal (LEAP), which took less than four months to deploy with the help of Qlik partner Icon Resources & Technologies (IRT), the organization is touted to overcome the challenge and complexity of handling large amounts of data while keeping the total cost-of-ownership low.
The combination of speed, accuracy and easy-to-assimilate Qlik visual dashboards is sought to offer a 360-degree view, which has accelerated decision-making and improved decision-making confidence throughout the organization. The success of the project has prompted plans for Lupin to roll out Qlik across the organization globally and centralize the planning, management and maintenance of its extensive IT infrastructure.
“Organizations want access to technologies that allow them to analyze data easily to derive trends and correlations so they are able to see the whole story,” said Souma Das, Managing Director, Qlik India. “Through our unique associative search capability, Qlik brings varied data sources together quickly so no data is left behind. Decision-makers at companies such as Lupin can be confident in the data they have access to, and enjoy the ability to derive insights freely in a governed manner.’’
With over 16,000 employees globally, Lupin is the third-largest pharmaceutical manufacturer by revenue in India and the fifth-largest generic pharmaceutical company in the US by prescription-led market share.